首页> 美国卫生研究院文献>Autopsy Case Reports >Clozapine-induced hypersensitivity myocarditis presenting as sudden cardiac death
【2h】

Clozapine-induced hypersensitivity myocarditis presenting as sudden cardiac death

机译:氯氮平诱发的超敏性心肌炎表现为心脏猝死

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hypersensitivity myocarditis is a rare but serious adverse effect of clozapine, a commonly used psychiatric drug. We report the case of sudden cardiac death from clozapine-induced hypersensitivity myocarditis diagnosed at autopsy. A 54-year-old Caucasian male on clozapine therapy for bipolar disorder presented with a sudden onset of shortness of breath. Laboratory studies were significant for elevated N-terminal prohormone of brain natriuretic peptide. During his hospital stay, the patient died of sudden cardiac arrest from ventricular tachycardia. The autopsy revealed hypersensitivity myocarditis, which usually occurs in the first 4 weeks after the initiation of clozapine. A 4-week monitoring protocol, including laboratory assessment of troponin and C-reactive protein, may assist in the early diagnosis of this potentially fatal condition.
机译:过敏性心肌炎是一种常用的精神科药物氯氮平罕见但严重的不良反应。我们报告了在尸检中诊断为氯氮平诱发的超敏性心肌炎导致心脏猝死的病例。一名接受氯氮平双相情感障碍治疗的54岁高加索男性,突然出现呼吸急促。实验室研究对于脑利钠肽N端激素水平升高具有重要意义。在住院期间,该患者因室性心动过速突然心脏骤停死亡。尸检显示过敏性心肌炎,通常发生在氯氮平起始后的前4周。为期4周的监测方案(包括肌钙蛋白和C反应蛋白的实验室评估)可能有助于这种潜在致命疾病的早期诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号